FDA Inspection 1208124 — Datascope Corp.

Datascope Corp. — FEI 3007965489

The FDA completed an inspection of Datascope Corp. on June 15, 2023 in Wayne, NJ. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 6 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 15, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
Wayne, NJ (United States)

Citations

IDCFRDescription
312121 CFR 820.80(b)Lack of or inadequate receiving acceptance procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
326221 CFR 820.250(a)Statistical techniques - Lack of or inadequate procedures
328221 CFR 820.90(a)Nonconforming product, Lack of or inadequate procedures
73221 CFR 803.50(a)(2)Individual Report of Malfunction
81221 CFR 803.56Submission of Supplement to Individual Report Within One Month